Search results for "Cytiva"
Article
Going Viral? Developing scalable viral vector manufacturing
Calling all Biotech Makers! We invite you to join our next interactive workshop where we have panellists from Virocell, AGC Biologics, Sensorion Pharma and Cytiva ready to share their kno…
Article
mRNA: the messenger
SEE HOW CYTIVA CAN HELP YOU >>
Article
Webcast: Repeatable, automated SPR titer assay for adeno- and adeno-associated viruses in crude samples
Fredrik Sundberg at Cytiva shares our recent SPR assay developments for measuring adenovirus and adeno-associated virus titers.
WATCH NOW >>
Article
Advanced therapeutics process development using mechanistic modeling
Guterstam
Watch the interview of Peter Guterstam and Nick Whitelock (Cytiva), and learn about
the biological background of advanced therapeutics
what mechanistic modelling …
Article
Get to know: mAb variants - eLearning
Cytiva has published an interactive course that gives an overview of monoclonal antibodies (mAbs) and current variants used and developed in academia and industry.
Key learnings are:
- Structure…
Article
Q&A: Oligonucleotide synthesis in process development and scale-up
Farlow
In this video, Greg Farlow, RNA/DNA synthesis product specialist at Cytiva, talks about the typical challenges with oligonucleotide synthesis in process development and key cons…
Article
Biotech Makers: Tools and top tips for faster process development
Listen to speakers from Byondis and Cytiva in our first 'Biotech Makers Workshops' event on the 30th March (2pm CET).
We will discuss top tips and tools for faster process developme…
Webcast
Improving the Oligonucleotide Synthesis Experience
Addressing this challenge was one of Cytiva’s main goals when we set out to develop a system for small-scale synthesis and process development.
Article
Improving the Oligonucleotide Synthesis Experience
Addressing this challenge was one of Cytiva’s main goals when we set out to develop a system for small-scale synthesis and process development.
>>> Watch the presentation
Article
Optimization of a Two-Step Purification Method for Bispecific Antibodies
Alligator and Cytiva developed an efficient downstream purification process for a cancer immunotherapy bispecific antibody (bsAb).
Read more